Etude 3000 ARTHROSES Symptomatic Knee and Hip Osteoarthritis Prevalence Survey

NCT01400529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2011-07-22

No results posted yet for this study

Summary

Nationwide descriptive epidemiology survey aiming to determine lower limb OA prevalence, based on a validated method previously used to assess inflammatory rheumatism (rheumatoid arthritis and spondylarthropathy) prevalence in France.

Conditions

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Francis Guillemin, MD, PhD · Societe Francaise de Rhumatologie

Eligibility

Min Age
40 Months
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01400529 on ClinicalTrials.gov